{"Name":"VistaGen Therapeutics","perma":"vistagen-therapeutics","BasicInfo":{"funded":"1998-01-01","isClosed":false,"closed":null,"short":"VistaGen is a biopharmaceutical company developing innovative product candidates for patients with diseases and disorders involving the CNS."},"FundingRounds":[{"funding_type":"post_ipo_equity","series":null,"announcedDate":"2016-06-02","moneyRaised":10000000},{"funding_type":"venture","series":null,"announcedDate":"2015-08-06","moneyRaised":1930281},{"funding_type":"undisclosed","series":null,"announcedDate":"2014-07-02","moneyRaised":1570000},{"funding_type":"post_ipo_equity","series":null,"announcedDate":"2013-04-10","moneyRaised":36000000},{"funding_type":"debt_financing","series":null,"announcedDate":"2012-03-07","moneyRaised":500000},{"funding_type":"venture","series":null,"announcedDate":"2008-12-22","moneyRaised":1000000},{"funding_type":"venture","series":null,"announcedDate":"2007-08-10","moneyRaised":3750000}],"Acquisitions":[],"AcquiredBy":null,"IPO":{"exchange":"NASDAQ","symbol":"VTGN","shares":null,"date":"2011-06-29","openPrice":null,"moneyRaised":null,"valuation":null},"Investments":[],"Products":[],"ProductsPermas":[],"CurrentTeam":[{"title":"CEO and Director","started":null,"ended":null,"firstName":"H.","lastName":"Ralph Snodgrass"},{"title":"President and Director","started":null,"ended":null,"firstName":"Shawn","lastName":"K. Singh"}],"PastTeam":[]}
